Abstract:Acute kidney injury (AKI) is a major concern in critically ill patients due to its impact on morbidity and mortality. Pathogenesis of AKI is complex and involves oxidative stress, tubular cell death, impaired mitochondrial function, prolonged cell-cycle arrest and inflammation. Inflammatory cells, specifically, myeloid cells (neutrophils and macrophages) accumulate within the injured kidney and regulate response via cross-talk signaling with the kidney parenchyma. Ferritins are evolutionarily conserved proteins involved in iron metabolism. Intracellular ferritins exist as a shell, comprising of two subunits, ferritin heavy chain (FtH) and ferritin light chain (FtL). FtH is a ferroxidase that oxidizes ferrous iron to the ferric form, which is then stored within the shell. In recently published work, we demonstrated that ferritins are important regulators of oxidative stress and inflammation. We also identified that loss of one protein chain is associated with a compensatory increase in the other chain. Therefore, we generated new and unique transgenic mice with targeted deletion of both proteins in the myeloid compartment.The purpose of this study was to determine the effect of myeloid ferritins on kidney injury and repair following AKI. We characterized the newly generated double transgenic mice by examining the expression of ferritins in myeloid cells of the bone marrow and spleen. We confirmed deletion of ferritins from the myeloid compartment and this deletion was associated with reduced intracellular iron levels. In quiescence, we found no difference in kidney function between the knockout and floxed wildtype male mice. However, 24 hours after 19-minute bilateral kidney ischemia reperfusion injury (IRI), we found that wildtype mice had significantly higher loss of kidney function compared to knockout mice, as evidenced by rise in serum creatinine and reduction in GFR. Interestingly, this effect persisted until 14 days following reperfusion. At 28 days, we identified that myeloid ferritin deletion was associated with better preserved kidney architecture and lesser fibrotic remodeling, as evident by lower induction of collagen 1, α-smooth muscle actin and TGF-β. Compared to knockout mice, we found that wildtype mice had significantly higher expression of kidney injury marker-1 and VCAM-1, a marker of inflammatory proximal tubular cells. These studies suggest that myeloid ferritins mediate cross-talk signaling with the kidney tubular epithelium and dictate the trajectory of kidney injury. Current studies are aimed at elucidating the impact of myeloid ferritins on neutrophil and macrophage trafficking to the injured kidney and to determine the role of myeloid ferritins in regulating inflammation and cross-talk signaling with the tubular epithelium to regulate kidney injury and repair. Importantly, our findings suggest that modulation of ferritin expression during AKI has the potential of being a novel therapeutic modality. NIH R01 DK122986 to SB This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury

Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension

Genetic and Pharmacological Inhibition of Fatty Acid-Binding Protein 4 Alleviated Inflammation and Early Fibrosis after Toxin Induced Kidney Injury.

Roles of Interferon Regulatory Factor 4 in the AKI-CKD Transition, Glomerular Diseases and Kidney Allograft Rejection

Inhibition of IL-18 Reduces Renal Fibrosis after Ischemia-Reperfusion.

MFAP4 deficiency alleviates renal fibrosis through inhibition of NF‐κB and TGF‐β/Smad signaling pathways

Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis

Natural Killer T Cell/il-4 Signaling Promotes Bone Marrow-Derived Fibroblast Activation and M2 Macrophage-to-myofibroblast Transition in Renal Fibrosis

IL-18 deficiency ameliorates the progression from AKI to CKD

Loss of FUT8 in Renal Tubules Ameliorates Ischemia-Reperfusion Injury-Induced Renal Interstitial Inflammation Transition to Fibrosis Via the TLR3-NF-B Pathway

Myeloid ferritins regulate injury and fibrosis following kidney ischemia reperfusion injury

KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury

4-1Bb-mediated Signals Confer Protection Against Folic Acid-Induced Nephrotoxicity

Upregulation of KLF14 Expression Attenuates Kidney Fibrosis by Inducing PPARα-Mediated Fatty Acid Oxidation

The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis

KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis

Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis

The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis

Calorie restriction exacerbates folic acid-induced kidney fibrosis by altering mitochondria metabolism

Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial–mesenchymal transition

Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition.